TC
PDLI

TFS Capital’s PDL BioPharma, Inc. PDLI Stock Holding History

TFS Capital’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-333,728
Closed -$824K – 583
2017
Q2 		$824K Buy
+333,728
New +$768K 0.32% 100
2016
Q3 		– Sell
-592,849
Closed -$1.86M – 1225
2016
Q2 		$1.86M Sell
592,849
-202,560
-25% -$675K 0.34% 27
2016
Q1 		$2.65M Sell
795,409
-853,674
-52% -$2.66M 0.38% 14
2015
Q4 		$5.84M Buy
1,649,083
+868,802
+111% +$3.64M 0.63% 16
2015
Q3 		$3.92M Buy
780,281
+197,843
+34% +$1.13M 0.38% 50
2015
Q2 		$3.75M Buy
582,438
+7,637
+1% +$51.2K 0.37% 55
2015
Q1 		$4.04M Buy
574,801
+389,576
+210% +$2.82M 0.4% 46
2014
Q4 		$1.43M Buy
185,225
+122,196
+194% +$967K 0.14% 219
2014
Q3 		$471K Sell
63,029
-334,363
-84% -$3.1M 0.04% 617
2014
Q2 		$3.85M Buy
397,392
+147,842
+59% +$1.32M 0.3% 65
2014
Q1 		$2.07M Sell
249,550
-394,664
-61% -$3.38M 0.14% 217
2013
Q4 		$5.44M Buy
644,214
+343,136
+114% +$2.89M 0.26% 93
2013
Q3 		$2.4M Sell
301,078
-560,691
-65% -$4.51M 0.11% 272
2013
Q2 		$6.65M Buy
+861,769
New +$6.72M 0.28% 61

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TFS Capital's PDLI Position: Q3 2017 in Review

TFS Capital sold out of PDL BioPharma, Inc. (PDLI) in Q3 2017, closing a stake of 333,728 shares — an estimated $824K sold.

TFS Capital first reported a position in PDLI in Q2 2013 and held it in 14 quarters. The position peaked at $6.65M in Q2 2013. 186 funds tracked by Wall St. Rank hold PDLI as of Q3 2017.

  • TFS Capital reported no remaining PDL BioPharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 333,728 PDL BioPharma, Inc. shares in Q3 2017, an estimated $824K.
  • TFS Capital first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 14 quarters.
  • TFS Capital's PDL BioPharma, Inc. position peaked at $6.65M in Q2 2013.
  • 186 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.